Burleson & Company, LLC Nektar Therapeutics Transaction History

Burleson & Company, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$16.52 - $20.4 $26,630 - $32,884	-1,612 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$16.56 - $25.46 $1.76 Million - $2.7 Million	-106,124 Reduced 98.5%	1,612 $32,000
Q4 2020 Feb 08, 2021	BUY	$15.77 - $19.03 $234,973 - $283,547	14,900 Added 16.05%	107,736 $1.83 Million
Q3 2020 Nov 10, 2020	BUY	$16.59 - $24.79 $348,390 - $520,590	21,000 Added 29.23%	92,836 $1.62 Million
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $379,350 - $527,400	22,500 Added 45.61%	71,836 $1.57 Million
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $331,883 - $641,290	22,936 Added 86.88%	49,336 $1.03 Million
Q4 2019 Feb 12, 2020	SELL	$15.87 - $23.12 $55,132 - $80,318	-3,474 Reduced 11.63%	26,400 $584,000
Q3 2019 Nov 12, 2019	BUY	$16.91 - $36.27 $280,706 - $602,082	16,600 Added 125.06%	29,874 $501,000
Q2 2019 Aug 05, 2019	BUY	$31.0 - $36.3 $89,900 - $105,269	2,900 Added 27.95%	13,274 $414,000
Q1 2019 May 09, 2019	BUY	$31.58 - $46.35 $103,456 - $151,842	3,276 Added 46.15%	10,374 $334,000
Q4 2018 Feb 27, 2019	BUY	$30.43 - $56.65 $15,215 - $28,325	500 Added 7.58%	7,098 $286,000
Q3 2018 Dec 06, 2018	BUY	$46.46 - $68.49 $306,543 - $451,897	6,598 New	6,598 $251,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $178M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Burleson & Company, LLC with notifications on news.